<p>In the latest episode of Pathfinders, Noël Brown, Head of US Biotechnology Investment Banking at RBC Capital Markets, reveals why he’s feeling optimistic about M&A in biopharma and how leading in biotech investment and corporates needs visionary long-term thinking.</p>

In the latest episode of Pathfinders, Noël Brown, Head of US Biotechnology Investment Banking at RBC Capital Markets, reveals why he’s feeling optimistic about M&A in biopharma and how leading in biotech investment and corporates needs visionary long-term thinking.

<p>In the latest episode of Pathfinders, Noël Brown, Head of US Biotechnology Investment Banking at RBC Capital Markets, reveals why he’s feeling optimistic about M&amp;A in biopharma and how leading in biotech investment and corporates needs visionary long-term thinking.</p>

Why Biopharma Investment Requires a Different Mindset

Perspectives from the cutting edge of biotech and pharma.

The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series.

Lead today. Define tomorrow.

Business

News

Investing

Business News

Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.

Share Why Biopharma Investment Requires a Different Mindset

Sign up to save your podcasts

Why Biopharma Investment Requires a Different Mindset

Why Biopharma Investment Requires a Different Mindset

More shows like Pathfinders in Biopharma

The Bill Simmons Podcast

RBC's Markets in Motion

Industries in Motion

Powering Sustainable Ideas

The Rest Is Politics

Macro Minutes

Strategic Alternatives

The Rest Is Politics: US